🔎 Trials Near Me

Hjem › Interstitielle lungesygdomme › Oklahoma

Interstitielle lungesygdomme kliniske forsøg i Oklahoma

5 studier for Interstitielle lungesygdomme søger deltagere på steder i Oklahoma.

Byer i Oklahoma

Officiel studietekst (engelsk)

Multi-site Study of the Clinical Impact of an AI-assisted Approach to Referring Patients With Interstitial Lung Disease for Diagnostic Evaluation of Pulmonary Hypertension

  • University of Oklahoma, Oklahoma City
Rekrutterer
Alder 18 og opefter · Alle køn · Opdateret 2. sep. 2026 · NCT06911632

DeciPHer-ILD: A Real-world Patient Registry in Group 3 Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)

  • The University of Oklahoma Health Sciences Center, Oklahoma City
  • Oklahoma Heart Institute, Tulsa
RekruttererObservationsstudie
Alder 18 og opefter · Alle køn · Opdateret 26. aug. 2026 · NCT06388421

Idiopathic Pulmonary Fibrosis and Interstitial Lung Disease Prospective Outcomes Registry

  • University of Oklahoma, Oklahoma City
RekruttererObservationsstudie
Alder 21 og opefter · Alle køn · Opdateret 12. aug. 2026 · NCT01915511

Study Evaluating INS018_055 Administered Orally to Subjects With Idiopathic Pulmonary Fibrosis

  • University of Oklahoma Health Sciences Center (OUHSC), Oklahoma City
RekruttererFase 2
Alder 40 og opefter · Alle køn · Opdateret 12. nov. 2025 · NCT05975983

Study to Evaluate the Efficacy, Safety, and Tolerability of Efzofitimod in Patients With Systemic Sclerosis (SSc)-Related Interstitial Lung Disease (ILD) (SSc-ILD)

  • aTyr Investigative Site, Oklahoma City
RekruttererFase 2
Alder 18 og opefter · Alle køn · Opdateret 7. maj 2025 · NCT05892614

Fra ClinicalTrials.gov, data hentet 3. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.